APA (7th ed.) Citation

MSI, S., K, S., Z, Z., RA, B., JK, W., AM, M., . . . KT, K. (2025). A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer. Cancer immunology, immunotherapy : CII, 75(1), 30. https://doi.org/10.1007/s00262-025-04271-1

Chicago Style (17th ed.) Citation

MSI, Saif, et al. "A Cytokine-based Serum Proteomic Score Is a Prognostic Biomarker for Immunotherapy in Head and Neck Cancer." Cancer Immunology, Immunotherapy : CII 75, no. 1 (2025): 30. https://doi.org/10.1007/s00262-025-04271-1.

MLA (9th ed.) Citation

MSI, Saif, et al. "A Cytokine-based Serum Proteomic Score Is a Prognostic Biomarker for Immunotherapy in Head and Neck Cancer." Cancer Immunology, Immunotherapy : CII, vol. 75, no. 1, 2025, p. 30, https://doi.org/10.1007/s00262-025-04271-1.